Alzheimer's: New Treatments Have Arrived in Greece - Who Can Receive Them and in Which Hospitals - iefimerida.gr
19 Articles
19 Articles
Already 35 patients are receiving the drug in seven hospitals – Neurologist-psychiatrist Paraskevi Sakka explains the benefits, side effects and administration criteria
The possibility of slowing down Alzheimer's disease with new treatments is now a reality in Greece. Already, at least 35 patients have been receiving a new monoclonal antibody in specialized hospitals in the country in the last year, with the results of clinical studies having already shown that this particular drug can significantly inhibit cognitive and functional deterioration in selected patients. “This is not a panacea or a definitive tre…
▶ New data in the treatment of Alzheimer's disease, with treatments that can slow the deterioration in selected patients, without however constituting a definitive solution A new therapeutic option for Alzheimer's disease is now available in Greece, offering prospects of slowing its progression in patients who meet specific criteria. At least 35 patients are receiving […]
Specialized hospitals in Greece are now administering donanemab, a monoclonal antibody that can slow cognitive and functional deterioration in selected patients with early Alzheimer's disease. As neurologist-psychiatrist and president of the Alzheimer Society of Athens Paraskevi Sakka reports to APE-MPE, 35 patients are already receiving the treatment in our country. However, she clarifies: […] Alzheimer's: The new treatment in Greece – Who does…
New medications for Alzheimer's disease are also administered in our country, in specialized hospitals and to carefully selected patients.
Coverage Details
Bias Distribution
- 100% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
